Cyrille J Cohen

8PUBLICATIONS
32CO-AUTHORS
Medical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 23, 2026
Computational design of optimized and preferentially paired human TCR constant regions for improved T cell function.

|Dec 09, 2024
Efficacy and Safety of Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis.

Eyal Lebel, Nathalie Asherie, Shlomit Kfir-Erenfeld

|Jul 22, 2024
Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T Cells.

Vasyl Eisenberg, Shiran Hoogi, Erel Katzman

|Jul 04, 2024
Genetically engineering glycolysis in T cells increases their antitumor function.

Raphaëlle Toledano Zur, Orna Atar, Tilda Barliya

|May 20, 2024
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma.

Shlomit Kfir-Erenfeld, Nathalie Asherie, Eyal Lebel

|Sep 15, 2022
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis.

Shlomit Kfir-Erenfeld, Nathalie Asherie, Sigal Grisariu

Pageof 2

Frequent Collaborators

3 joint publications

Eyal Lebel

3 joint publications

Nathalie Asherie

3 joint publications

Marjorie Pick

3 joint publications

Moshe E Gatt